title: American Diabetes Association position statement: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications.
abstract: Medical nutrition therapy for people with diabetes should be individualized, with consideration given to the individual's usual food and eating habits, metabolic profile, treatment goals and desired outcomes. Monitoring of metabolic parameters, including glucose, HbA1c, lipids, blood pressure, body weight, and renal function, when appropriate, as well as quality of life is essential to assess the need for changes in therapy and ensure successful outcomes. Ongoing nutrition self-management education and care needs to be available for individuals with diabetes. Additionally many areas of nutrition and diabetes require additional research.
mesh_terms: D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002648:Child; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000178:diet therapy* / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000178:diet therapy; D003924:Diabetes Mellitus, Type 2 / Q000178:diet therapy; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D004041:Dietary Fats / Q000008:administration & dosage; D004044:Dietary Proteins / Q000008:administration & dosage; D004734:Energy Metabolism; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007774:Lactation; D018673:Nutrition Policy; D009765:Obesity; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000178:diet therapy; D012955:Societies, Medical; D013549:Sweetening Agents
chemical_list: D001786:Blood Glucose; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004044:Dietary Proteins; D013549:Sweetening Agents